Analysis of angiogenesis biomarkers for ramucirumab (RAM) efficacy in patients with metastatic colorectal cancer (mCRC) from RAISE, a global, randomized, double-blind, Phase 3 study

Annals of Oncology
September 1, 2017
Cited by 3Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis